Javascript must be enabled to continue!
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
View through CrossRef
Immunotherapeutic PD-1–targeted therapies require CD28 to promote cancer cell killing.
American Association for the Advancement of Science (AAAS)
Title: T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
Description:
Immunotherapeutic PD-1–targeted therapies require CD28 to promote cancer cell killing.
Related Results
Imbalance between CD8+CD28+ and CD8+CD28– T-cell subsets and its clinical significance in patients with systemic lupus erythematosus
Imbalance between CD8+CD28+ and CD8+CD28– T-cell subsets and its clinical significance in patients with systemic lupus erythematosus
Objective The aim of this study was to evaluate the changes in CD8+CD28–/CD8+CD28+ T-cell subset balance and in the CD8+CD28– Treg cell number and function in patients with systemi...
High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.
High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.
Abstract
Background: Although CAR-T cell therapy has revolutionized the treatment of hematologic malignancies, durable r...
Modulation of Graft-Versus-Host Disease Induced by Central Memory Suicide Gene Modified Human T Lymphocytes.
Modulation of Graft-Versus-Host Disease Induced by Central Memory Suicide Gene Modified Human T Lymphocytes.
Abstract
Background. Suicide gene therapy is a promising approach for the safe exploitation of the graft-versus-leukemia effect. The insertion of Herpes Simplex Viru...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
T cell co-stimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
T cell co-stimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
AbstractProgrammed death-1 (PD-1) is a co-inhibitory receptor that suppresses T cell activation and is an important cancer immunotherapy target. Upon activation by its ligand PD-L1...
Unicar: A Novel Modular Retargeting Platform Technology for CAR T Cells
Unicar: A Novel Modular Retargeting Platform Technology for CAR T Cells
Abstract
The adoptive transfer of T cells engineered with chimeric antigen receptors (CARs) is currently considered as a highly promising therapeutic option for trea...
The cellular and signaling requirements of effector CD8⁺T cells during influenza A virus infection
The cellular and signaling requirements of effector CD8⁺T cells during influenza A virus infection
Experimental data from previous studies on T cell activation suggests that naive T cells are programmed at initiation in the lymph nodes by mature antigen presenting cells, to unde...
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...

